AI Regulation in MedTech w. Dr. David Blumenthal

About this episode

Generative AI doesn't act like a medical device. It acts like a form of intelligence, and Dr. David Blumenthal thinks it should be overseen like one. Blumenthal, the Harvard-trained physician and policy expert who ran the $25 billion federal rollout of electronic health records under Obama, joins Shannon Lantzy to lay out a new framework for regulating AI as a practitioner rather than a tool. They trace the parallel between physician training and AI development, debate whether FDA is even the right agency for the job, and dig into why nobody actually measures doctor error rates. The conversation moves through Operation Warp Speed, the economics of EHR adoption, and a look ahead at fully automated hospital wings.

Timestamps:

[00:00:00] Introduction and AI's promise and peril in healthcare

[00:03:00] David's path from Capitol Hill to primary care to the Commonwealth Fund

[00:12:00] Operation Warp Speed as a model for fast, safe innovation

[00:20:00] Why FDA safety review protects the market as much as patients

[00:25:00] Meaningful use and the human side of EHR adoption

[00:32:00] Defining generative AI: intelligence, not medical device

[00:36:00] Borrowing physician licensing to oversee AI

[00:44:00] Comparing human training to AI accreditation

[00:52:00] Who should regulate agentic AI in the clinic

[00:56:00] Measuring error rates: doctors versus algorithms

[01:04:00] Economic incentives and how AI adoption differs by system

[01:08:00] Science fiction, robotic surgery, and rapid fire

Follow Shannon and David:

Connect with Shannon: 

LinkedIn: https://www.linkedin.com/in/shannonlantzy/

Website: https://www.shannonlantzy.com/

Connect with David: 

Website: https://www.hks.harvard.edu/about/david-blumenthal